CV Seprafilm - for reduction of adhesions following open-heart surgery

From: Helen Dynda (olddad66@runestone.net)
Thu May 11 15:00:06 2000


* Genzyme's CV Seprafilm has received European marketing approval for the reduction of adhesions following open-heart surgery.

Genzyme hopes to file for U.S. Food and Drug Administration (FDA) approval in 2001.

http://www.genzyme.com/ir/gzsp99/page3.html


Enter keywords:
Returns per screen: Require all keywords: